tiprankstipranks
Amylyx Pharmaceuticals Inc (AMLX)
NASDAQ:AMLX
US Market
Holding AMLX?
Track your performance easily

Amylyx Pharmaceuticals Inc (AMLX) Ownership - Who Owns Amylyx Pharmaceuticals Inc?

517 Followers

Amylyx Pharmaceuticals Inc (AMLX) Ownership Overview

16.89%8.84%28.70%6.79%38.79%
16.89% Insiders
28.70% Other Institutional Investors
6.79% ETFs
38.79% Public Companies and
Individual Investors
The ownership structure of Amylyx Pharmaceuticals Inc (AMLX) stock is a mix of institutional, retail, and individual investors. Approximately 44.32% of the company’s stock is owned by Institutional Investors, 16.89% is owned by Insiders, and 38.79% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 02, 2024
Justin B. Klee
Co Ceo,director
xxxxxxxxxxxxx
$59299
Oct 02, 2024
Joshua B Cohen
Co Ceo,director
xxxxxxxxxxxxx
$59299
Oct 02, 2024
xxxxxxxxxxxxx
$36500
Oct 02, 2024
xxxxxxxxxxxxx
$27782

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$220177
Sep 30, 2024
xxxxxxxxxxxxx
$2169137
Sep 30, 2024
xxxxxxxxxxxxx
$6887102

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,415,785Institution4.98%17,864,556
3,202,381Insider4.70%16,748,453
3,220,569Insider4.70%16,843,576
3,184,259Insider4.65%16,653,675
2,962,555Institution4.32%15,494,163
2,563,205Institution3.74%13,405,562
2,125,649Institution3.10%11,117,144
1,150,221Institution1.68%6,015,656
936,967Institution1.37%4,900,337
858,571Insider1.25%4,490,326

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,415,785Institution4.98%17,864,556
384,510Institution0.56%2,010,987
348,375Institution0.51%1,822,001
342,895Institution0.50%1,793,341
300,790Institution0.44%1,573,132
254,005Institution0.37%1,328,446
157,412Institution0.23%823,265
147,666Institution0.22%772,293
130,000Institution0.19%679,900
114,800Institution0.17%600,404

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,811,143Institution2.64%9,780,172
600,395Institution0.88%3,242,133
387,802Institution0.57%1,912,177
289,758Institution0.42%1,515,434
271,246Institution0.40%1,418,617
246,958Institution0.36%1,289,121
183,055Institution0.27%955,547
183,055Institution0.27%955,547
153,875Institution0.22%830,925
142,910Institution0.21%747,419

FAQ

Who Owns Amylyx Pharmaceuticals Inc (AMLX)?
According to the latest TipRanks data, approximately 28.70% of the company's stock is held by institutional investors, 16.89% is held by insiders, and 38.79% is held by retail investors.
    What percentage of Amylyx Pharmaceuticals Inc (AMLX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 28.70% of Amylyx Pharmaceuticals Inc (AMLX) stock is held by institutional investors.
      What percentage of Amylyx Pharmaceuticals Inc (AMLX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 38.79% of Amylyx Pharmaceuticals Inc (AMLX) stock is held by retail investors.
        Who owns the most shares of Amylyx Pharmaceuticals Inc (AMLX)?
        VANGUARD INDEX FUNDS owns the most shares of Amylyx Pharmaceuticals Inc (AMLX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis